4.1 Article

Functional Impairment in the Diagnosis of Mild Cognitive Impairment

期刊

ALZHEIMER DISEASE & ASSOCIATED DISORDERS
卷 25, 期 3, 页码 225-229

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WAD.0b013e318209d517

关键词

mild cognitive impairment; functional activity; diagnostic criteria; predictive validity; dementia

资金

  1. Pfizer Global Pharmaceuticals [06-05-039]
  2. Ministry for Health, Welfare and Family Affairs, Republic of Korea [A092077]
  3. Esai Korea
  4. Wyeth Pharmaceuticals
  5. Eli Lilly
  6. H. Lundbeck A/S
  7. Ministry of Health and Welfare, Korea

向作者/读者索取更多资源

The criterion on functional activity in the revised diagnostic criteria for mild cognitive impairment (MCI) seems to be conceptually and operationally problematic. We investigated the predictive validity for dementia of this criterion in 140 patients with MCI who participated in the baseline study of the Korean Longitudinal Study on Health and Aging and completed 18-month follow-up evaluation (mean duration of follow-up, 1.57 +/- 0.24 y). Annual conversion rates to dementia were compared between the patients who fulfilled the criterion on functional activity and those who did not. Annual conversion rates to dementia of the patients who fulfilled the criterion on functional activity was 4.76%, whereas that of the patients with MCI who did not was 33.07%, indicating that the criterion on functional activity was a significant negative predictor of dementia (odds ratio = 0.12). Re-revision of the criterion on functional activity may be warranted to solve its conceptual and operational ambiguities.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据